Download PDF
Thromb Haemost 1989; 62(02): 807-810
DOI: 10.1055/s-0038-1646908
Scientific and Standardization Committee Communications
Schattauer GmbH Stuttgart

The Utility of Plasma Fibrinopeptide Assays

John Owen
For the Fibrinogen Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Hemostasis
› Author Affiliations
Further Information

Publication History

Received 02 March 1989

Accepted after revision 26 April 1989

Publication Date:
30 June 2018 (online)

Also available at
  PDF Download  Permissions and Reprints
 

  • References

  • 1 Nossel HL, Yudelman I, Canfield RE, Butler Jr VP, Spanondis K, Wilner GD, Qureshi GD. Measurement of fibrinopeptide A in human blood. J Clin Invest 1974; 54: 43-53
    CrossrefPubMedSearch in Google Scholar
  • 2 Holvoet P, Lijnen HR, Collen D. A monoclonal antibody preventing binding of tissue-type plasminogen activator to fibrin: useful to monitor fibrinogen breakdown during t-PA infusion. Blood 1986; 67: 1482-1487
    PubMedSearch in Google Scholar
  • 3 Kockum C, Frebelius S. Rapid radioimmunoassay of human fibrinopeptide A - removal of cross-reacting fibrinogen with bentonite. Thromb Res 1980; 19: 589-598
    CrossrefPubMedSearch in Google Scholar
  • 4 Eckhardt T, Nossel HL, Hurlet Jensen A, LaGamma KS, Owen J, Auerbach M. Measurement of desarginine fibrinopeptide B in human blood. J Clin Invest 1981; 67: 809-816
    CrossrefPubMedSearch in Google Scholar
  • 5 Nichols AB, Owen J, Kaplan KL, Sciacca RR, Cannon PJ, Nossel HL. Fibrinopeptide A, platelet factor 4, and beta-thromboglobulin levels in coronary heart disease. Blood 1982; 60: 650-654
    PubMedSearch in Google Scholar
  • 6 Leeksma OC, Meijer Huizinga F, Stoepman van Dalen EA, van Ginkel CJ, van Aken WG, van Mourik JA. Fibrinopeptide A and the phosphate content of fibrinogen in. venous thromboembolism and disseminated intravascular coagulation. Blood 1986; 67: 1460-1467
    PubMedSearch in Google Scholar
  • 7 Koehn JA, Canfield RE. Purification of human fibrinopeptides by high-performance liquid chromatography. Anal Biochem 1981; 116: 349-356
    CrossrefPubMedSearch in Google Scholar
  • 8 Kudryk B, Rohoza A, Ahadi M, Chin J, Wiebe ME. A monoclonal antibody with ability to distinguish between NH2-terminal fragments derived from fibrinogen and fibrin. Mol Immunol 1983; 20: 1191-1200
    CrossrefPubMedSearch in Google Scholar
  • 9 Canfield RE, Dean J, Nossel HL, Butler Jr VP, Wilner GD. Reactivity of fibrinogen and fibrinopeptide A containing fibrinogen fragments with antisera to fibrinopeptide A. Biochemistry 1976; 15: 1203-1209
    CrossrefPubMedSearch in Google Scholar
  • 10 Nossel HL, Butler Jr VP, Wilner GD, Canfield RE, Harfenist EJ. Specificity of antisera to human fibrinopeptide A used in clinical fibrinopeptide A assays. Thromb Haemostas 1976; 35: 101-109
    PubMedSearch in Google Scholar
  • 11 Wilner GD, Nossel HL, Canfield RE, Butler Jr VP. Immunochemical studies of human fibrinopeptide A using synthetic peptide homologues. Biochemistry 1976; 15: 1209-1213
    CrossrefPubMedSearch in Google Scholar
  • 12 Bilezikian SB, Nossel HL. Unique pattern of fibrinogen cleavage by human leukocyte proteases. Blood 1977; 50: 21-28
    PubMedSearch in Google Scholar
  • 13 Weitz JI, Landman SL, Crowley KA, Birken S, Morgan FJ. Development of an assay for in vivo neutrophil elastase activity. Increased elastase activity in patients with alpha-1-proteinase inhibitor deficiency. J Clin Invest 1986; 78: 155-162
    CrossrefPubMedSearch in Google Scholar
  • 14 Mombelli G, Roux A, Haeberli A, Straub PW. Comparison of 125I- fibrinogen kinetics and fibrinopeptide A in patients with disseminated neoplasias. Blood 1982; 60: 381-388
    PubMedSearch in Google Scholar
  • 15 Peuscher FW, Cleton FJ, Armstrong L, Stoepman van Dalen EA, Van Mourik JA, van Aken WG. Significance of plasma fibrinopeptide A (fpA) in patients with malignancy. J Lab Clin Med 1980; 96: 5-14
    PubMedSearch in Google Scholar
  • 16 Owen J, Friedman KD, Grossman B, Wilkins C, Berke AD, Powers ER. Quantitation of fragment X formation during thrombolytic therapy with streptokinase and with tissue plasminogen activator. J Clin Invest 1987; 79: 1642-1647
    CrossrefPubMedSearch in Google Scholar
  • 17 Alkjaersig N, Fletcher AP. Catabolism and excretion of fibrinopeptide A. Blood 1982; 60: 148-156
    PubMedSearch in Google Scholar